To investigate whether the co-expression of CBX8 and PD-L1 can be used to predict the prognostic value for patients with cervical cancer, the patients were divided into 3 groups based on the expression of CBX8 and PD-L1: those with low expression of CBX8 and PD-L1, those with high expression of CBX8 and low expression of PD-L1 or low expression of CBX8 and high expression of PD-L1, and those with high expression of CBX8 and PD-L1. This evidence concerns the gene CBX8 and cervical carcinoma.